Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Embecta Corp. on behalf of investors who purchased Embecta common stock between November 25, 2025 and May 4, 2026. The lawsuit alleges that the company made materially false and misleading statements about its financial results and guidance, particularly regarding its pen needle business. On May 5, 2026, Embecta reported second-quarter earnings below expectations and cut its full-year 2026 guidance, citing a loss in its pen needle product category and soft market volume. Following the news, Embecta shares fell approximately 58%, from $9.25 to $3.90. Investors have until August 17, 2026 to seek lead plaintiff appointment.
Embecta CorpClass action lawsuit alleging misleading statements about financial results and guidance, causing 58% stock drop.